AstraZeneca

Iseq in Dublin closes the session up 1.3%

Therapies include those designed to target people with compromised immune systems

Building and travel stocks struggle on Iseq

Twitter stock tanks after Elon Musk puts $44bn deal on hold, but Tesla stock rises

State news agency says number of people in Pyongyang have contracted Omicron variant

Bargain-hunters enter market after sell-off on economic worries

With the virus rampant despite jabs, trials are underway to create intranasal vaccines

Zelenskiy tells leaders at conference of need for ‘practical steps’ towards EU membership

Pyongyang says it has kept its population Covid-free by sealing the country’s borders

Iseq down 0.5% as travel and leisure names weaken

Adoption of committee reports confirms extension intended to facilitate travel

US shares fall on inflation worries

Cantillon: Emerging markets surprise observers with vaccine preferences

Only inpatients will have access to Paxlovid; sotrovimab deemed ineffective against BA.2

Iseq boosted by banks and building stocks

Impact of sanctions on Russia also contribute to stock market declines

Tech stocks keep the Nasdaq riding high

America Letter: As cases threaten to rise, release of funds falls prey to partisan politics

‘We don’t need to push it in places we are not needed or wanted,’ says drugmaker’s VP

Iseq drops 1.6% on Monday as banks and travel stocks drag it down

European Medicines Agency says no evidence to suggest vaccines affect fertility

Ryanair, AstraZeneca and Disney among the climbers as tech stocks drop

Sales for Covid-19 products expected to decline, profit margins to be lower

Equities still headed for their worst January since 2016

Most are mild to moderate and many had resolved or were resolving when reported

Drug-maker to submit data to regulators worldwide given urgent need for boosters

Order will push total US purchase to 1.2 million doses of coronavirus antibody drug

Analysis: There are far bigger issues for Nphet to resolve around inoculation policy

In a sequel to 2020 no one wanted, some thrived, some slumped and some were unlucky

Iseq All-Share Index rises 0.9% to 8,444.96 to reach highest level in more than six weeks

Prof Tess Lambe to continue tradition of Irish scientists delivering Royal Institution Christmas lecture

Pandemic and protocol will continue to dominate political life in the months ahead

Triumph of science is the big story this year, but we still struggle with the truth

Few would bet on the PM remaining in office another year or the royal family making up

Investors’ appetites for risk increases as fears recede over economic impact of Omicron

European shares hit two-week highs on Thursday as investor sentiment improved

The data suggests those infected in UK are 40 per cent less likely to be hospitalised for a night or more

Other vaccine producers also studying potential for adapted formulations

Just 13 per cent of people in Africa have received at least one dose of a Covid vaccine

Validity will be extended after booster shot without a time limit